Abstract
Objectives
To evaluate the outcome of staging chest CT and to identify clinicoradiological factors predictive of lung metastasis in patients with hepatoblastoma based on the 2017 PRE-Treatment EXTent of tumor (PRETEXT) system.
Methods
This bi-center study retrospectively identified patients diagnosed with hepatoblastoma between January 1998 and September 2019 in two tertiary hospitals. The primary outcome was the proportion of the patients who had lung metastasis at staging chest CT. The diagnostic accuracy of staging chest CT was calculated based on the 2017 PRETEXT criteria. The secondary outcome was the identification of factors predictive of lung metastasis using multivariable logistic regression.
Results
In total, 123 patients (median age, 1 year; interquartile range, 0–4 years; 59 female) were included. Among those, 28% (35/123; 95% confidence interval [CI], 21–37%) had lung metastasis at staging chest CT. The overall accuracy of staging chest CT was 96.8%. The proportion of lung metastasis in patients with stage I, II, III, and IV was 0%, 24% (12 of 49; 95% CI, 14–38%), 23% (9 of 40; 95% CI, 12–38%), and 56% (14 of 25; 95% CI, 37–73%), respectively. Multifocality (adjusted odds ratio, 6.7; 95% CI, 2.7–17.5; p < .001) and male sex (adjusted odds ratio, 3.1; 95% CI, 1.2–8.6; p = .02) were associated with the presence of lung metastasis.
Conclusions
Twenty-eight percent of the patients with hepatoblastoma had lung metastasis at staging chest CT. Multifocality and male sex were predictive factors for lung metastasis on staging chest CT.
Key Points
• The proportion of lung metastasis in patients with hepatoblastoma was 28%.
• The overall accuracy of staging chest CT was 97% based on the 2017 PRETEXT system.
• Hepatic tumor multifocality and male sex were predictors of lung metastasis.
Similar content being viewed by others
Abbreviations
- AFP:
-
Alpha-fetoprotein
- CT:
-
Computed tomography
- OR:
-
Odds ratio
- PRETEXT system:
-
PRE-Treatment EXTent of tumor system
- STROBE:
-
Strengthening the Reporting of Observational Studies in Epidemiology
References
Perilongo G, Shafford EA (1999) Liver tumours. Eur J Cancer 35:953–958 discussion 958-959
Meyers RL, Maibach R, Hiyama E et al (2017) Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children’s Hepatic tumors International Collaboration. Lancet Oncol 18:122–131
Perilongo G, Shafford E, Maibach R et al (2004) Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2. Eur J Cancer 40:411–421
Ortega JA, Krailo MD, Haas JE et al (1991) Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group. J Clin Oncol 9:2167–2176
Brown J, Perilongo G, Shafford E et al (2000) Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 36:1418–1425
Perilongo G, Brown J, Shafford E et al (2000) Hepatoblastoma presenting with lung metastases: treatment results of the first cooperative, prospective study of the International Society of Paediatric Oncology on childhood liver tumors. Cancer 89:1845–1853
O'Neill AF, Towbin AJ, Krailo MD et al (2017) Characterization of pulmonary metastases in children with hepatoblastoma treated on Children’s Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): a report from the Children’s Oncology Group. J Clin Oncol 35:3465
Towbin AJ, Meyers RL, Woodley H et al (2018) 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol 48:536–554
Agarwala S, Gupta A, Bansal D et al (2017) Management of hepatoblastoma: ICMR consensus document. Indian J Pediatr 84:456–464
Cancer Committee from American Pediatric Surgical Association (2018) Handbook for children with liver tumors. American Pediatric Surgical Association Available via https://www.eapsa.org/apsa/media/Documents/HandbooksonCancerSurgery/Handbook_Liver_Tumors_Spring2018.pdf. Accessed 21 Mar 2020
von Elm E, Altman DG, Egger M et al (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335:806–808
Yoon HM, Hwang J, Kim KW et al (2019) Prognostic factors for event-free survival in pediatric patients with hepatoblastoma based on the 2017 PRETEXT and CHIC-HS Systems. Cancers 11:1387
Czauderna P, Haeberle B, Hiyama E et al (2016) The Children’s Hepatic tumors International Collaboration (CHIC): novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Eur J Cancer 52:92–101
Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246:697–722
Lee KH, Park JH, Kim YH et al (2018) Diagnostic yield and false-referral rate of staging chest CT in patients with colon cancer. Radiology 289:535–545
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174
Bland JM, Altman DG (2007) Agreement between methods of measurement with multiple observations per individual. J Biopharm Stat 17:571–582
Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228–247
Wong SY, Hynes RO (2006) Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide? Cell Cycle 5:812–817
Shi Y, Commander SJ, Masand PM, Heczey A, Goss JA, Vasudevan SA (2017) Vascular invasion is a prognostic indicator in hepatoblastoma. J Pediatr Surg 52:956–961
Kiruthiga KG, Ramakrishna B, Saha S, Sen S (2018) Histological and immunohistochemical study of hepatoblastoma: correlation with tumour behaviour and survival. J Gastrointest Oncol 9:326–337
Yuan XJ, Wang HM, Jiang H et al (2016) Multidisciplinary effort in treating children with hepatoblastoma in China. Cancer Lett 375:39–46
Funding
This study was supported by a grant (2020IE0016) from Asan Medical Center Children’s Hospital (Heart Institute), Seoul, Korea, and the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2020R1G1A1004591).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Hee Mang Yoon.
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Statistics and biometry
No complex statistical methods were necessary for this paper.
One of the authors has significant statistical expertise.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Ethical approval
Institutional Review Board approval was obtained.
Study subjects or cohorts overlap
Some study subjects have been reported in our previous study (HM Yoon Et al Prognostic factors for event-free survival in pediatric patients with hepatoblastoma base on the 2017 PRETEXT and CHIC-HS systems. 2019. Cancers).
Methodology
• retrospective
• observational
• multicenter study
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
ESM 1
(DOCX 2444 kb)
Rights and permissions
About this article
Cite this article
Kim, P.H., Hwang, J., Yoon, H.M. et al. Outcome of staging chest CT and identification of factors associated with lung metastasis in children with hepatoblastoma. Eur Radiol 31, 8850–8857 (2021). https://doi.org/10.1007/s00330-021-08047-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-021-08047-w